Drug name - Nayzilam

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687495 UCB INC Methods and systems for the delivery of a therapeutic agent Jan, 2028

(5 years from now)

US9289432 UCB INC Methods and compositions for the delivery of a therapeutic agent Jan, 2028

(5 years from now)

US8217033 UCB INC Methods and compositions for the delivery of a therapeutic agent Jan, 2028

(5 years from now)

US8809322 UCB INC Methods and compositions for the delivery of a therapeutic agent Jan, 2028

(5 years from now)

Drugs and Companies using MIDAZOLAM ingredient

Treatment: Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient's usual seizure pattern in patients with epilepsy 12 years of age and older

Dosage: SPRAY;NASAL

More Information on Dosage
Strength Dosage Availability
5MG/SPRAY SPRAY;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.